1 May 2014 in American Journal of Ophthalmology
1 June 2020 in Acta Biochimica et Biophysica Sinica
Clear cell renal cell carcinoma (ccRCC) is a common malignancy of the genitourinary system and is associated with high mortality rates. However, the molecular mechanism of ccRCC pathogenesis is still unclear, which translates to few effective diagnostic and prognostic biomarkers. In this study, we conducted a bioinformatics analysis on three Gene Expression Omnibus datasets and identified 437 differentially expressed genes (DEGs) related to ccRCC development and prognosis, of which 311 and 126 genes are respectively down-regulated and up-regulated. The protein-protein interaction network of these DEGs consists of 395 nodes and 1872 interactions and 2 prominent modules. The Staphylococcus aureus infection and complement and coagulation cascades are significantly enriched in module 1 and are likely involved in ccRCC progression. Forty-two hub genes were screened, of which von Willebrand factor, TIMP metallopeptidase inhibitor 1, plasminogen, formimidoyltransferase cyclodeaminase, solute carrier family 34 member 1, hydroxyacid oxidase 2, alanine-glyoxylate aminotransferase 2, phosphoenolpyruvate carboxykinase 1, and 3-hydroxy-3-methylglutaryl-CoA synthase 2 are possibly related to the prognosis of ccRCC. The differential expression of all nine genes was confirmed by quantitative real-time polymerase chain reaction analysis of the ccRCC and normal renal tissues. These key genes are potential biomarkers for the diagnosis and prognosis of ccRCC and warrant further investigation.
28 July 2021 in Journal of Ocular Pharmacology and Therapeutics
Purpose: Many researchers have reported that vitamin A (VA) deficiency is related to chalazion. The purpose of this article is to clarify the effects of VA supplementation on chalazion in young children with VA deficiency. Methods: Forty-eight young children with VA deficiency suffering from chalazia were enrolled from our previous studies and were followed continuously for 1 year. Serum VA levels and recurrence of chalazion were observed. Results: The mean serum VA levels increased after supplementation ( P = 2.17E-15). The mean serum VA levels of subjects who experienced recurrence were lower than those without recurrence ( P = 0.015). The recurrence rate and the mean recurrent frequency after supplementation were lower than before supplementation ( P = 0.01, P = 6E-6); the mean time to the first recurrence of subjects without recurrence was longer after supplementation than before supplementation ( P < 0.01). Conclusions: Oral VA supplementation could reduce the recurrence of chalazion in young children with preexisting VA deficiency.
18 January 2019 in BMC Ophthalmology
To identity the effect of lacrimal system irrigation in the acute stage in children with Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). A retrospective review of 39 patients with SJS or TEN from 2012 to 2017 was analyzed. Patients were divided into two subgroups according to whether they received irrigation in the acute stage. The irrigation group included 21 inpatients and the control group included 18 inpatients. The χ2 test was used to compare clinical findings and data in both groups. The rate of lacrimal system obstructions in the chronic stage of SJS or TEN in the irrigation group was significantly lower than in the control group (p < 0.01). A significant difference was also found between the epiphora rates in patients with SJS or TEN in the chronic stage in the two groups (p = 0.047). One of 15 patients with mild dry eyes or without dry eyes in the irrigation group had epiphora, and it affected five of 12 in the control group. The difference between the two groups was significant (p = 0.03). Epiphora in the two patients in the control group was long-term, owing to the disappearance of puncta marks. Lacrimal system irrigation with dexamethasone drops in the acute stage was a simple way to lessen lacrimal system obstructions and epiphora in patients with SJS or TEN. It should be considered a conventional ocular treatment for SJS or TEN.
20 January 2015 in European Journal of Ophthalmology
Purpose: To examine the effect of proximal drainage plus lacrimal sac massage in patients with congenital dacryocystoceles. Methods: A retrospective review of 77 patients was performed. Traditional massage was performed in the traditional treatment group (35 patients) first. Proximal lacrimal sac drainage plus massage of the lacrimal sac using a Bangerter lacrimal cannula (defined as modified massage) was performed in the modified group (42 patients). Probing was undertaken if the treatments failed in both groups. Success rates of decompression of lacrimal sac and recovery rate were observed. The χ2 test was used to compare the groups. Results: Success rates of decompression of lacrimal sac were 100% in the modified group and 31% in the traditional group. In the modified group, 34 patients with 37 dacryocystoceles (80%) recovered with the modified treatment within 14 days. However, in the traditional group, only 11 patients with 12 dacryocystoceles (30%) had resolution after conservative treatment. The recovery rate of the modified massage in the modified group was higher than that of massage alone in the traditional group (p<0.001). As to the individuals receiving probing, 8 patients with 9 dacryocystoceles (100%) in the modified group were successful, while 18 patients with 21 dacryocystoceles (78%) in the traditional group had a satisfying effect. Conclusions: Proximal drainage plus massage has the advantage of high efficiency and safety for the treatment of congenital dacryocystoceles.